Table 2.
Correlation pattern of leukocyte Nampt/PBEF/visfatin (L-Nampt).
| Parameter | Non-IBD Controls (IBS) | IBD | |
|---|---|---|---|
| CD | UC | ||
| Hb (g/L) | ρ= −0.46, p = 0.047 | ρ= −0.34, p = 0.025 | ρ= −0.36, p = 0.032 |
| PLT (×109/L) | ρ= −0.08, p = 0.753 | ρ = 0.34, p = 0.024 | ρ = 0.32, p = 0.061 |
| WBC (×109/L) | ρ = 0.21, p = 0.387 | ρ = 0.45, p = 0.003 | ρ = 0.38, p = 0.025 |
| ESR (mm/h) | ρ= −0.02, p = 0.926 | ρ = 0.08, p = 0.821 | ρ = 0.19, p = 0.511 |
| hsCRP (mg/L) | ρ = 0.28, p = 0.334 | ρ = 0.33, p = 0.054 | ρ = 0.66, p < 0.001 |
| IL1B (NRQ) | ρ = 0.33, p = 0.163 | ρ= −0.09, p = 0.566 | ρ = 0, p = 0.977 |
| TNFA (NRQ) | ρ = 0.26, p = 0.286 | ρ = 0.17, p = 0.271 | ρ = 0.28, p = 0.102 |
| IL8 (NRQ) | ρ = 0.52, p = 0.023 | ρ = 0.13, p = 0.384 | ρ= −0.14, p = 0.429 |
| VEGFA (NRQ) | ρ = 0.14, p = 0.567 | ρ = 0.63, p < 0.0001 | ρ = 0.48, p = 0.003 |
Data are presented as Spearman correlation coefficient (ρ). Hb, hemoglobin; PLT, platelet count; WBC, white blood cell count; ESR, erythrocyte sedimentation rate; hsCRP, high-sensitive C-reactive protein; IL, interleukin; TNFA, tumor necrosis factor; VEGFA, vascular endothelial growth factor; IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis.